ESMO Preceptorship on Head and Neck Zurich 2019 banner

Start date: 07 May 2019
End date: 08 May 2019
Location: Zurich, Switzerland

Learning objectives

To understand epidemiology, etiology, and molecular biology of squamous cell carcinoma of the head and neck
To understand multidisciplinary management and treatment of head and neck cancer
To learn about advances in the treatment and novel targets in head and neck cancer
To learn about salivary gland cancer

Accreditation

The programme of this event has been accredited with 10 ESMO-MORA Cat. 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further information please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

Viktor Grünwald, Germany, DE
Jean-Pascal Machiels, Belgium, BE